Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'cariprazine hydrochloride'

Search results for: 'cariprazine hydrochloride'

Items 21-30 of 753

Page
per page
  1. Higenamine hydrochloride
    C6665 Higenamine hydrochloride
      ≥57.7 mg/mL
  2. Ethyl-L-NIO (hydrochloride)
    C4663 Ethyl-L-NIO (hydrochloride)
    Summary: modestly selective NOS inhibitor
      ≤2 mg/mL
  3. S-methyl-L-Thiocitrulline (hydrochloride)
    C5504 S-methyl-L-Thiocitrulline (hydrochloride)
    Summary: potent NOS inhibitor
      ≤75 mg/mL
  4. Betaine hydrochloride
    N1700 Betaine hydrochloride
      insoluble in EtOH; ≥20.15 mg/mL
  5. Pexidartinib hydrochloride
    A4687 Pexidartinib hydrochloride
      ≥49 mg/mL
  6. AP-III-a4 hydrochloride
    B8912 AP-III-a4 hydrochloride
      ≥49.8 mg/mL
  7. Defactinib hydrochloride
    A4651 Defactinib hydrochloride
      ≥15.75 mg/mL
  8. Vandetanib hydrochloride
    A3906 Vandetanib hydrochloride
    Summary: VEGFR/EGFR inhibitor
      ≥51.2 mg/mL
  9. PJ34 hydrochloride
    A4159 PJ34 hydrochloride
    Summary: PARP inhibitor,potent and cell-permeable
      insoluble in H2O; insoluble in EtOH; ≥16.6 mg/mL
  10. AT7519 Hydrochloride
    A3197 AT7519 Hydrochloride
    Target: Cyclin-Dependent Kinases
    Summary: Multi-CDK inhibitor
      ≥29.93 mg/mL

Items 21-30 of 753

Page
per page
Shop By
Shopping Options
Category
  1. Signaling Pathways618item
  2. Natural Products13item
  3. Amino Acids & Building Blocks1 item
  4. Screening Library33item
  5. Probes & Dyes2item
  6. Protein & Immunology2item
  7. Lab Reagents14item
  8. Biochemical Reagent31item
Specificity
  1. Selective44item
  2. Non-Selective1 item
Reversibility
  1. Reversible3item
  2. Irreversible1 item
Target
  1. Cyclin-Dependent Kinases2item
  2. Histone Deacetylases (HDACs)1 item
  3. Akt2item
  4. PI3K1 item
  5. Raf1 item
  6. Aurora Kinases1 item
  7. EZH21 item
  8. mTOR1 item
  9. Thymidine Phosphorylases1 item
  10. GSK-31 item
  11. VEGFR1 item
  12. PDGFR1 item
  13. c-Kit1 item
  14. Phosphodiesterases (PDEs)1 item
  15. p381 item
  16. GABAB Receptors1 item
  17. Sir2-like Family Deacetylases (Sirtuins)1 item
  18. Src1 item
  19. Aminopeptidases1 item
  20. NMDA Receptors1 item
  21. EGFR2item
  22. ROCK1 item
  23. FAK1 item
  24. Syk1 item
  25. DNA-PK1 item
  26. HSP901 item
  27. Gutathione S-transferase1 item
  28. Adenosine Kinases1 item
  29. Serine Proteases1 item
  30. PKC1 item
  31. M1 Receptors1 item
  32. Ca2 /calmodulin-dependent protein kinases (CaMKs)2item
  33. Pyk21 item
  34. 5-HT2 Receptors2item
  35. S1P receptors1 item
  36. PARP1 item
  37. ALK1 item
  38. PKG1 item
  39. PKA1 item
  40. Myosin light chain kinases (MLCKs)2item
  41. 5-HT3 Receptors1 item
  42. Histamine H4 Receptors1 item
  43. Squalene epoxidases1 item
  44. Nampt1 item
  45. P2X Receptors1 item
  46. Glutamate (Metabotropic) Group I Receptors1 item
  47. Urokinases1 item
  48. Histamine H1 Receptors2item
  49. Sigma Receptors2item
  50. Apoptosis Inducers1 item
  51. Inward Rectifier Potassium (Kir) Channels1 item
  52. c-RET1 item
  53. guanylyl cyclase1 item
  54. dopamine receptor1 item
  55. 5-HT1 Receptor1 item
  56. 5-HT2 Receptor1 item
  57. NMPRTase1 item
  58. PARs1 item
  59. Dipeptidyl-peptidase II1 item
  60. adrenoceptor1 item
  61. 5-HT6 Receptor1 item
  62. haspin kinase1 item
  63. IKK1 item
  64. Antibiotic1 item
  65. Calmodulins1 item
  66. Calcium-Sensing Receptors (CaSRs)2item
  67. PAR receptor1 item
  68. NOS1 item
  69. TRPC channel1 item
  70. GABAA receptor1 item
  71. CRF1 Receptors1 item
Reported Experiments
  1. Animal Experiments65item
  2. Cell Experiments62item
Related Disease
  1. Acute Myeloid Leukemia1 item
  2. Bacterial Infectios1 item
  3. Bladder Cancer2item
  4. Breast Cancer4item
  5. Cancer22item
  6. Chronic Lymphocytic Leukemia1 item
  7. Colon Cancer3item
  8. Colorectal Cancer2item
  9. Glioblastoma2item
  10. Glioma2item
  11. Hepatocellular Carcinoma1 item
  12. Inflammatory Diseases2item
  13. Leukemia1 item
  14. Lung Cancer3item
  15. Melanoma1 item
  16. Multidrug Resistance Studies1 item
  17. Multiple Myeloma2item
  18. Narcolepsy1 item
  19. Non-small Cell Lung Cancer1 item
  20. Ovarian Cancer1 item
  21. Pancreatic Cancer2item
  22. Prostate Cancer3item
  23. Type 2 Diabetes1 item